Cargando…

Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an underdiagnosed condition sharing risk factors with lung cancer. Lung cancer screening may provide an opportunity to improve COPD diagnosis. Using Pan-Canadian Early Detection of Lung Cancer (PanCan) study data, the present study sought t...

Descripción completa

Detalles Bibliográficos
Autores principales: Goffin, John R., Pond, Gregory R., Puksa, Serge, Tremblay, Alain, Johnston, Michael, Goss, Glen, Nicholas, Garth, Martel, Simon, Bhatia, Rick, Liu, Geoffrey, Schmidt, Heidi, Atkar-Khattra, Sukhinder, McWilliams, Annette, Tsao, Ming-Sound, Tammemagi, Martin C., Lam, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670711/
https://www.ncbi.nlm.nih.gov/pubmed/33198781
http://dx.doi.org/10.1186/s12890-020-01344-y
_version_ 1783610793273589760
author Goffin, John R.
Pond, Gregory R.
Puksa, Serge
Tremblay, Alain
Johnston, Michael
Goss, Glen
Nicholas, Garth
Martel, Simon
Bhatia, Rick
Liu, Geoffrey
Schmidt, Heidi
Atkar-Khattra, Sukhinder
McWilliams, Annette
Tsao, Ming-Sound
Tammemagi, Martin C.
Lam, Stephen
author_facet Goffin, John R.
Pond, Gregory R.
Puksa, Serge
Tremblay, Alain
Johnston, Michael
Goss, Glen
Nicholas, Garth
Martel, Simon
Bhatia, Rick
Liu, Geoffrey
Schmidt, Heidi
Atkar-Khattra, Sukhinder
McWilliams, Annette
Tsao, Ming-Sound
Tammemagi, Martin C.
Lam, Stephen
author_sort Goffin, John R.
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an underdiagnosed condition sharing risk factors with lung cancer. Lung cancer screening may provide an opportunity to improve COPD diagnosis. Using Pan-Canadian Early Detection of Lung Cancer (PanCan) study data, the present study sought to determine the following: 1) What is the prevalence of COPD in a lung cancer screening population? 2) Can a model based on clinical and screening low-dose CT scan data predict the likelihood of COPD? METHODS: The single arm PanCan study recruited current or former smokers age 50–75 who had a calculated risk of lung cancer of at least 2% over 6 years. A baseline health questionnaire, spirometry, and low-dose CT scan were performed. CT scans were assessed by a radiologist for extent and distribution of emphysema. With spirometry as the gold standard, logistic regression was used to assess factors associated with COPD. RESULTS: Among 2514 recruited subjects, 1136 (45.2%) met spirometry criteria for COPD, including 833 of 1987 (41.9%) of those with no prior diagnosis, 53.8% of whom had moderate or worse disease. In a multivariate model, age, current smoking status, number of pack-years, presence of dyspnea, wheeze, participation in a high-risk occupation, and emphysema extent on LDCT were all statistically associated with COPD, while the overall model had poor discrimination (c-statistic = 0.627 (95% CI of 0.607 to 0.650). The lowest and the highest risk decile in the model predicted COPD risk of 27.4 and 65.3%. CONCLUSIONS: COPD had a high prevalence in a lung cancer screening population. While a risk model had poor discrimination, all deciles of risk had a high prevalence of COPD, and spirometry could be considered as an additional test in lung cancer screening programs. TRIAL REGISTRATION: (Clinical Trial Registration: ClinicalTrials.gov, number NCT00751660, registered September 12, 2008) SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-020-01344-y.
format Online
Article
Text
id pubmed-7670711
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76707112020-11-18 Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population Goffin, John R. Pond, Gregory R. Puksa, Serge Tremblay, Alain Johnston, Michael Goss, Glen Nicholas, Garth Martel, Simon Bhatia, Rick Liu, Geoffrey Schmidt, Heidi Atkar-Khattra, Sukhinder McWilliams, Annette Tsao, Ming-Sound Tammemagi, Martin C. Lam, Stephen BMC Pulm Med Research Article BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an underdiagnosed condition sharing risk factors with lung cancer. Lung cancer screening may provide an opportunity to improve COPD diagnosis. Using Pan-Canadian Early Detection of Lung Cancer (PanCan) study data, the present study sought to determine the following: 1) What is the prevalence of COPD in a lung cancer screening population? 2) Can a model based on clinical and screening low-dose CT scan data predict the likelihood of COPD? METHODS: The single arm PanCan study recruited current or former smokers age 50–75 who had a calculated risk of lung cancer of at least 2% over 6 years. A baseline health questionnaire, spirometry, and low-dose CT scan were performed. CT scans were assessed by a radiologist for extent and distribution of emphysema. With spirometry as the gold standard, logistic regression was used to assess factors associated with COPD. RESULTS: Among 2514 recruited subjects, 1136 (45.2%) met spirometry criteria for COPD, including 833 of 1987 (41.9%) of those with no prior diagnosis, 53.8% of whom had moderate or worse disease. In a multivariate model, age, current smoking status, number of pack-years, presence of dyspnea, wheeze, participation in a high-risk occupation, and emphysema extent on LDCT were all statistically associated with COPD, while the overall model had poor discrimination (c-statistic = 0.627 (95% CI of 0.607 to 0.650). The lowest and the highest risk decile in the model predicted COPD risk of 27.4 and 65.3%. CONCLUSIONS: COPD had a high prevalence in a lung cancer screening population. While a risk model had poor discrimination, all deciles of risk had a high prevalence of COPD, and spirometry could be considered as an additional test in lung cancer screening programs. TRIAL REGISTRATION: (Clinical Trial Registration: ClinicalTrials.gov, number NCT00751660, registered September 12, 2008) SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-020-01344-y. BioMed Central 2020-11-16 /pmc/articles/PMC7670711/ /pubmed/33198781 http://dx.doi.org/10.1186/s12890-020-01344-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Goffin, John R.
Pond, Gregory R.
Puksa, Serge
Tremblay, Alain
Johnston, Michael
Goss, Glen
Nicholas, Garth
Martel, Simon
Bhatia, Rick
Liu, Geoffrey
Schmidt, Heidi
Atkar-Khattra, Sukhinder
McWilliams, Annette
Tsao, Ming-Sound
Tammemagi, Martin C.
Lam, Stephen
Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population
title Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population
title_full Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population
title_fullStr Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population
title_full_unstemmed Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population
title_short Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population
title_sort chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670711/
https://www.ncbi.nlm.nih.gov/pubmed/33198781
http://dx.doi.org/10.1186/s12890-020-01344-y
work_keys_str_mv AT goffinjohnr chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT pondgregoryr chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT puksaserge chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT tremblayalain chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT johnstonmichael chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT gossglen chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT nicholasgarth chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT martelsimon chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT bhatiarick chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT liugeoffrey chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT schmidtheidi chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT atkarkhattrasukhinder chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT mcwilliamsannette chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT tsaomingsound chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT tammemagimartinc chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation
AT lamstephen chronicobstructivepulmonarydiseaseprevalenceandpredictioninahighrisklungcancerscreeningpopulation